MedTrace Logo

Study of Echinaforce Junior Tablets in Children With Acute Colds

NCT02198391 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2021-05-04

No results posted yet for this study

Summary

This study aims to investigate safety and efficacy of Echinaforce Junior tablets in two dosages of 3 x 1 and 5 x 1 tablets per day in children 4 - 12 years old with acute colds.

Conditions

  • Respiratory Tract Diseases

Sponsors & Collaborators

  • A. Vogel AG

    lead INDUSTRY

Principal Investigators

  • Arnold Baechler, Dr. med. · Facharzt FMH für Kinder- u. Jugendmedizin, Notkerstrasse 14 9006 St. Gallen, Switzerland

Eligibility

Min Age
4 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-15
Primary Completion
2015-08-07
Completion
2015-08-07

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02198391 on ClinicalTrials.gov